Related references
Note: Only part of the references are listed.Cumulative Use of Strong Anticholinergics and Incident Dementia A Prospective Cohort Study
Shelly L. Gray et al.
JAMA INTERNAL MEDICINE (2015)
Temporal trends in anticholinergic medication prescription in older people: repeated cross-sectional analysis of population prescribing data
Deepa Sumukadas et al.
AGE AND AGEING (2014)
Characterizing mild cognitive impairment in incident Parkinson disease The ICICLE-PD Study
Alison J. Yarnall et al.
NEUROLOGY (2014)
Short latency afferent inhibition: A biomarker for mild cognitive impairment in Parkinson's disease?
Alison J. Yarnall et al.
MOVEMENT DISORDERS (2013)
Prognosis of Mild Cognitive Impairment in Early Parkinson Disease
Kenn Freddy Pedersen et al.
JAMA NEUROLOGY (2013)
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
Irene Litvan et al.
MOVEMENT DISORDERS (2012)
Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
Yaroslau Compta et al.
BRAIN (2011)
Anticholinergic Medication Use and Cognitive Impairment in the Older Population: The Medical Research Council Cognitive Function and Ageing Study
Chris Fox et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2011)
Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study
Uwe Ehrt et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
Caroline H. Williams-Gray et al.
BRAIN (2009)
Anticholinergic activity of 107 medications commonly used by older adults
Marci L. Chew et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2008)
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
Mariese A. Hely et al.
MOVEMENT DISORDERS (2008)
Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale Presentation and Clinimetric Testing Results
Christopher G. Goetz et al.
MOVEMENT DISORDERS (2008)
The anticholinergic drug scale as a measure of drug-related anticholinergic burden: Associations with serum anticholinergic activity
Ryan M. Carnahan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Subtypes of mild cognitive impairment in Parkinson's disease: Progression to dementia
Carmen Cristea Janvin et al.
MOVEMENT DISORDERS (2006)
The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment
ZS Nasreddine et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs
EK Perry et al.
ANNALS OF NEUROLOGY (2003)
Cholinergic dysfunction in diseases with Lewy bodies
P Tiraboschi et al.
NEUROLOGY (2000)
Share Paper
